SUBSTITUIERTE XANTHINDERIVATE

Patent europeic · EP3199203 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP3199203
Numer da la dumonda
EP17160882
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
27-02-2009
Publitgà
02-08-2017
Concedì
05-02-2020
Stritgà
29-02-2020
Motiv
Taxa annuala betg pajada
Classas IPC
A61P 13/12 (2006.01)
A61P 1/16 (2006.01)
C07D 473/06 (2006.01)
A61K 31/522 (2006.01)
Prioritad
US 67736 P 29.02.2008
US 134568 P 11.07.2008
US 198715 P 07.11.2008
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-09-2020

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.09.2020

  2. 05-02-2020

    Concedì

    Published in Swissreg on 05.02.2020

Partidas

Possessur

Concert Pharmaceuticals, Inc.

Concert Pharmaceuticals Inc.

65 Hayden Avenue, Suite 3000N, Lexington, MA 02421, US

Inventur

HARBESON, Scott, L.

Cambridge, MA Massachusetts 02140, US

TUNG, Roger, D.

Lexington, MA Massachusetts 02420, US

LIU, Julie, F.

Lexington, MA Massachusetts 02420, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.